The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved US$9.2 billion for grants starting in 2024. 152 new grants will begin implementation this month, supporting more than 70 countries to continue their lifesaving work to end the three epidemics and build sustainable and climate-resilient systems for health over the 2024-2026 period.
The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved US$9.2 billion for grants starting in 2024. 152 new grants will begin implementation this month, supporting more than 70 countries to continue their lifesaving work to end the three epidemics and build sustainable and climate-resilient systems for health over the 2024-2026 period.
06 May 2021
GENEVA – The Global Fund has approved US$75 million in fast-track funding to support India’s response to the COVID-19 crisis that is devastating the country. This new funding will support India in purchasing oxygen concentrators and Pressure Swing Adsorption (PSA) oxygen plants to help meet the medium-term needs for medical oxygen.
India is currently facing a severe scarcity of oxygen and is recording its highest daily coronavirus death toll since the pandemic began, with 3,780 deaths in the past 24 hours alone. Alongside corticosteroids, medical oxygen is the only proven lifesaving treatment for the most seriously ill COVID-19 patients. Without oxygen, COVID-19 patients suffering from hypoxaemia – an abnormally low level of oxygen in the blood – will likely die.